Use of PCR to Evaluate Renal Allograft Status (Diagnostic and Serial Biopsies)
Study Status
Open to Enrollment
Study Description
This is a prospective study of kidney or combined kidney/pancreas transplant recipients to examine potential biological markers (genes expressed in blood, urine and kidney tissue) of transplant kidney status that may be able to predict rejection. Rejection is a process where the body’s immune cells attack the transplant kidney, which the body considers as foreign. Doctors generally perform a biopsy (taking a small portion of the transplant kidney using a needle) to determine if there is rejection.
Sponsor
NIH; Qatar National Research Foundation (QNRF); Quest Diagnostics, Inc.
Key Eligibility
- Men and women age 18-85 who have received a kidney transplant or combined kidney/pancreas tranplant
- Must be able to provide informed consent
Principal Investigator
Contact
- Tessa Scott, MPH
- 212-746-6914
- [email protected]
Healthy Volunteers
As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.
Contact Us
For general inquiries, or if you need assistance finding a study, please contact:
Robert Hagerty
Subject Recruitment Manager
Tel: (646) 962-9340
[email protected]